Locations:
Search
Phase 1 study demonstrates immune response in three quarters of patients with triple-negative breast cancer
Multidisciplinary teams bring pathological and clinical expertise
Uterine transposition cleared the field for radiation therapy
Genetic variants exist irrespective of family history or other contributing factors
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Study shows significantly reduced risk of mortality and disease complications in patients receiving GLP-1 agonists
Structured interventions enhance sleep, safety and caregiver resiliency in high-acuity units
Addressing rare disease and challenging treatment course in an active young patient
Large retrospective study suggests DOACs are safe, effective alternative to low-molecular-weight heparin in complex patient population
Study shows high rate of hematologic responses, low rate of disease progression
Bispecific antibody bridging therapy deepens durability of BCMA CAR T-cell therapy without overlapping toxicities in patients with relapsed/refractory multiple myeloma
Advertisement
Advertisement